Keywords
Zebrafish embryo, xenograft, cancer, melanoma, prostate cancer, metastasis, replacement
This article is included in the NC3Rs gateway.
Zebrafish embryo, xenograft, cancer, melanoma, prostate cancer, metastasis, replacement
The new version of this article has been updated to, confirm details of when and how the experiment is terminated; reference FIJI imaging software as a method of analysis; emphasise the importance of establishing a baseline for the invasion of different cancer cell lines and the use of tracer beads to evaluate movement associated with organ development; reference other uses of this model such as analysis of angiogenesis or cancer cell proliferation; document product codes of important materials used; and confirm details of how 3D printed moulds were created. A new version of Supplementary File 1 has been provided. Figure 3 has also been updated to account for the different analysis used.
See the authors' detailed response to the review by Yi Feng
See the authors' detailed response to the review by Adam Hurlstone
Only a small number of cancer cells (100–200 cells per fish) are required.
Use of fluorescent cell markers in conjunction with transgenic zebrafish lines allows for host cells to be distinguished from human cancer cells in real-time/in situ, avoiding the need for post-mortem immunocytochemistry.
The zebrafish embryo assay is higher-throughput than mouse xenograft models.
Metastasis is a clinical term describing the spread of tumour cells from a primary location to distant sites. It is suggested that more than 90% of deaths from cancer are not caused by the primary tumour but by the direct effects of metastatic deposits and from the metabolic burden of a rapidly growing tumour cell mass (Jemal et al., 2011). Traditionally an orderly cascade of cellular behaviours was presumed to underlie the progression from a well circumscribed and localised tumour growth to distant spread, based on initial local invasion, entry into the vascular or lymphatic system, survival in those fluid channels followed by extravasation and colonisation in a distal site (Massagué et al., 2017). However, this orderly progression is not borne out by current research and the mechanisms of metastatic spread remain controversial. The role of epithelial to mesenchymal transformation (EMT) is unclear and plasticity of cells that metastasise and their relationship to the primary tumour cells, e.g. stem cells, remains the object of current research (Pandya et al., 2017). Furthermore, cancers do not appear to disseminate randomly, but exhibit tropism for specific organs, especially lung, liver and bone (Tarin, 2011). This observation, made over 100 years ago by Steven Paget, led to the "seed and soil" hypothesis which remains unproven. In clinical practice, surgical resection or local treatment of primary tumours is effective, but metastases remain difficult to treat. This is particularly evident for melanoma, where localised and slow-growing metastatic deposits can appear long after apparent cure (Gershenwald & Scolyer, 2018). Similarly, in prostatic cancer the primary site is rarely a clinical problem in comparison to the pain and pathological fractures from osteolytic vertebral deposits (Akakura et al., 1996).
Understanding the multi-step processes that regulate cancer metastasis will likely result in new therapeutics to benefit patients with a wide range of cancers at different stages of progression. Although in vitro systems, e.g. the artificial skin model for melanoma (Hill et al., 2015) can be highly effective for studying primary tumour behaviour, connected organ systems are needed to understand metastasis. The mouse has traditionally been used as a pre-clinical model organism to study cancer under the rationale that they are a mammalian species, with the same organ systems as humans. Although genetically modified animals do spontaneously develop tumours, the introduction of human tumour cells into other species, xenografting, is a vital pre-clinical tool that enables researchers to study tumour metastasis and evaluate drug responses (van Marion et al., 2016). Xenografts provide greater experimental control and can provide a direct translational link to the patient, particularly when the developmental origin of cancer remains unknown. However within a mouse, metastatic spread from xenografts often occurs late, well after the primary deposit has become distressing to the animal, and further pain can also result from the aggressive invasive nature of the metastases (Gómez-Cuadrado et al., 2017). Highly metastatic cell lines are often used to accelerate the development of metastatic tumours, but these may not reflect normal metastasis, and therefore several different lines must be used, requiring many more animals (Cruz-Munoz et al., 2008). It is sometimes possible to surgically remove the primary tumour prior to analysis of metastatic dissemination (Srivastava et al., 2014); however, this is often associated with excessive tissue damage requiring prolonged post-operative analgesia. Direct injection of cancer cells into the tail vein (Elkin & Vlodavsky, 2001; Minn et al., 2005), heart (Kang et al., 2003), illiac artery (Bos et al., 2009; Wang et al., 2015), spleen (Morikawa et al., 1988), peritoneum (Chu et al., 2015) or tibia (Fisher et al., 2002) have all been used to model local metastatic behaviours, but the mouse model is limited since metastasising single cells cannot be tracked and only relatively large metastatic growths can be detected, precluding study of the earliest metastatic events. Furthermore, mouse models have also had limited success when predicting anti-cancer drug efficacy in human trials (Day et al., 2015; Kersten et al., 2017).
The zebrafish is a tropical bony fish which for over 30 years has been increasingly used in developmental biology and human disease modelling as it contains almost all human organ systems except lungs (Penberthy et al., 2002). The zebrafish genome has been sequenced and there is a high degree of conserved genes and genetic signalling pathways compared to humans (Howe et al., 2013). Importantly for the study of cancer metastasis, embryos are completely transparent, facilitating imaging at single cell level within developing organs whilst also imaging the entire animal. Furthermore, the majority of studies can be carried on early-stage embryos before they are capable of independent feeding, which for the zebrafish is widely considered to be 5 days post fertilisation (dpf), and protected under the Animals (Scientific Procedures) Act (ASPA) and EU Directive (2010/63/EU). The extra-uterine development of hundreds of eggs also permits a greater number of studies in genetically identical organisms. Since the first reported xenotransplantation of human cells into zebrafish (Lee et al., 2005), many laboratories have shown that zebrafish embryos are useful for the study of other facets of tumour biology including cancer-induced angiogenesis (Britto et al., 2018; Haldi et al., 2006; Nicoli et al., 2007); cancer cell invasion and metastasis (de Boeck et al., 2016; Marques et al., 2009); cancer stem cell growth (Bansal et al., 2014; Chen et al., 2017); interaction of cancer cells with the host (Feng & Martin, 2015); and drug screening (Corkery et al., 2011; Gibert et al., 2013). Importantly, the development of human tumours and their response to chemotherapeutic treatment in zebrafish embryos is comparable to that observed in mouse xenograft assays (Fior et al., 2017). Additionally, while mouse xenograft models require immuno-deficient mice to prevent immune-rejection of the human cancer cells, the lack of a mature adaptive immune system within zebrafish embryos up to 14 dpf allows analysis of human cancers without rejection (Lam et al., 2004).
In this article we describe the techniques for performing embryonic zebrafish xenograft experiments and demonstrate the utility of using zebrafish embryos as a model system for studying human cancer metastasis, in particular metastatic melanoma and prostate cancer. We highlight the advantages over mouse xenograft models and provide a practical experimental protocol showing how zebrafish embryos can be used as a replacement for mice to conveniently study metastatic tumour behaviour in the laboratory.
A full step-by-step protocol can be found in Supplementary File 1.
Transparent Casper Tg(kdrl;GFP) zebrafish were housed under standard conditions at 28.5°C (Westernfield, 2000). All animals were maintained under UK Home Office project licence 604548 according to the requirements of the Animals (Scientific Procedures) Act 1986 of the UK Government and conformed to Directive 2010/63/EU of the European Parliament. Zebrafish eggs were collected by timed pair mating and incubated in E3 media at 28.5°C in air until 48 hours post fertilisation (hpf). A completed ARRIVE checklist can be found in Supplementary File 2. Embryos are maintained under anaesthesia where appropriate and killed prior to 120 hpf using a schedule 1 method. For individual embryos this can be through destruction of the brain using forceps, or for larger numbers destruction of the brain can be assured using a polythene rolling pin.
Human melanoma cells A375 (American Type Culture Collection (ATCC), Manassas, USA; RRID, CVCL_0132), as well as C8161 (RRID, CVCL_6813) and WM164 (RRID, CVCL_7928) (generously gifted by Professor Meenhard Herlyn, The Wistar Institute, Philadelphia, USA), or PC-3M-Pro4-mCherry prostate cancer cells (ATCC; RRID, CVCL_D579), were incubated at 33°C for 24 hours to precondition cells prior to staining with 1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI; Vybrant red fluorescent dye; Invitrogen, Paisley, UK) and injection into zebrafish embryos.
Zebrafish embryos at 2 dpf were immobilised using 1.2 mM tricaine methanesulfonate, which is a water soluble, fast-acting anaesthetic agent. Zebrafish embryos were then embedded in a thin film of low-melting-point agarose to stabilise the fish in a lateral position. To investigate invasion of cancer cells from the extravascular compartment into the vasculature, approximately 250 Dil-labelled melanoma cells in a volume of 5 nl were injected into the inferior section of the yolk sac. Similarly, to investigate tissue tropism of cancer cells, 250 DiI-labelled prostate cancer cells in a volume of 5 nl were injected into the vein of Cuvier. Following injection, fish were carefully removed from the agarose/tricaine solution using Dumont No5 fine forceps and transferred individually into 96-well plate imaging chambers created from 1% agarose using 3D printed pins (Wittbrodt et al., 2014). Minor orientation was required and embryos were suitable for microscopic analysis within 2 hours of injection.
Confocal images (250 μm total z-depth) of each fish were captured at 0, 24 and 72 hour time points, or every 15 mins for 5 hours for time-lapse imaging, using an inverted Leica SP8 confocal microscope (Leica Microsystems, GmbH Heidelberg, Germany) at 405 nm (blue FluoSpheres), 488 nm (green blood vessels) and 564 nm (red cells). The movement of DiI-positive melanoma cells was analysed using Volocity 3D Image Analysis Software (Volocity 6.3; PerkinElmer, Waltham, Massachusetts, USA) by manually measuring the two-dimensional distance moved by individual melanoma cells from site of injection. This analysis could alternatively be performed using ImageJ to measure the calibrated pixel distance. The number of RFP-expressing prostate cancer cells was analysed using ImageJ software version 1.8.0_112 (https://imagej.nih.gov/ij) to quantify the total area and intensity of RFP fluorescence.
For the analysis of tissue-specific homing of prostate cancer cells, 2 dpf zebrafish embryos from a pool of embryos derived from several mated adult zebrafish pairs were randomly assigned to receive an injection of PBS, or an injection of cancer cells, into the vein of Cuvier. The experimental unit is the individual zebrafish embryo, and a sample size of 4 embryos per group was selected on the basis of a normal standard deviation set at 95% confidence level (z = 1.96), a confidence interval (c) of 0.05 and assuming an effect size of 90% (p = 0.9) based on pilot experiments, according to the formula: n = (2z(p)(1-p))/2c. Measurement of total RFP-fluorescence within confocal images was performed and analysed using two-tailed Student’s t-test by a second researcher using GraphPad Prism 7 software (Graph Pad, San Diego, CA USA).
The initial event in metastatic spread is the movement of an individual cancer cell from the tumour niche. This can be modelled using in-vitro systems such as skin organoids or the Dunn chemotactic chamber, but neither of these assays are suitable for measuring metastasis. In our zebrafish embryo xenograft model, we inject small deposits of fluorescently labelled human cancer cells into the yolk sac at 2 dpf, and track individual cells until 5 dpf (Figure 1A). By using a zebrafish line with absent pigmentation it is possible to achieve excellent views throughout transgenic embryos with GFP-labelled endothelial blood vessels (green; 510 nm emission), ensuring injection of DiI-labelled A375 melanoma cells (red; 565 nm emission) into the extravascular compartment (Figure 1Bi), which directly migrate to peripheral sites (Figure 1Bii. Although embryos are normally allowed to develop at 28.5°C and human cells at 37°C, a compromise at 33°C works well. The movement of individual melanoma cells from site of injection can be measured using ImageJ or Volocity image analysis software (Figure 1C).
The ability to carry out time-lapse imaging on embryos affords the opportunity to examine individual cell movement. Injected embryos were lightly anaesthetised using tricaine and orientated in low-melting-point agarose. By focusing on the point of injection, DiI-labelled melanoma cells were visualised moving through the extravesicular compartment within the yolk sac of zebrafish embryos using low-voltage time-lapse confocal microscopy (Figure 2A and Supplementary Movie 1). A 3D-rendering of the confocal image z-stack was rotated to reveal the transverse section of the blood vessel showing a melanoma cell positioned between the zebrafish endothelial cells, indicating that this cell is directly within the blood vessel (Figure 2Ax and Supplementary Movie 2).
Haematological or lymphatic metastatic dissemination requires interaction with the endothelium during entry and exit. However, patients can also have cancer cells circulating in their blood that do not necessarily show metastases (Reymond et al., 2013). It is now recognised that metastasising cells exhibit sticking and rolling as they interact with the endothelium, and surface molecules such as selectins and CD44 are implicated. The zebrafish embryo xenograft model shows potential to be an extremely powerful tool in understanding the relationship between the surface biology of tumour and endothelial cells. Time-lapse confocal microscopy at 15-minute intervals readily captured melanoma cells as they demonstrated sticking and rolling behaviours on the surface of vascular endothelium (Figure 2B and Supplementary Movie 3) clearly suggesting a specific interaction of the human melanoma cells with zebrafish endothelial cells.
Tumour cells can also be directly injected into the circulation of developing zebrafish via the vein of Cuvier providing a tractable model of metastatic cancer cell-endothelial interaction during vascular exit. This is particularly important in some tumours that do not readily enter the vasculature, but do have tissue tropic exit routes. For example, the prostate cancer cell line PC-3M-Pro4-mCherry does not metastasise from the yolk sac, but when injected into the circulation these cells seed in the caudal hematopoietic tissue of the zebrafish tail where they proliferate, suggesting a specific microenvironmental niche favourable for tumour development (Figure 3A, B).
A specific benefit of embryonic zebrafish over other larger preclinical laboratory models is that several experiments can be carried out in parallel on the same microscope stage. This allows screening of a library of pharmacological candidates, but importantly evaluation of different metastatic cell types, which may be primary cell lines derived directly from patients. This is important as heterogeneity between or within patient tumours may be important in metastatic behaviour. We have seen this in our own melanoma work, where C8161 cells disseminated widely throughout the yolk sac (Figure 3C) while WM164 cells formed a localised tumour-like mass with fewer melanoma cells invading the yolk sac (Figure 3D). Co-injection of tracer beads can be used to distinguish passive developmental associated movement from active migration and invasion of cancer cells. Metastatic A375 cells were found in the distal tail vessels, whilst very few C8161 and WM164 cells were found in the tail and other regions of the zebrafish by 72hpf, indicating C8161 and WM164 cells have a reduced capacity to invade blood vessels, which may limit their metastatic potential.
These vital imaging-based assays used in combination with the ability to genetically modify zebrafish or apply pharmacological agents represent important new tools and approaches to understand these metastatic processes at a cellular level.
We and others have shown that xenotransplantation of human cancer into zebrafish embryos can be optimally carried out at 48 hfp when gastrulation is complete and the main body plan of the animal is established. The next 72 hours provides sufficient time frame to model key stages of metastatic behaviour, including local invasion, vascular entry, circulation and vascular exit. In this paper we have demonstrated how tumour invasion and/or metastatic dissemination by human cancer cells can be monitored through time-lapse microscopy. Most importantly, metastatic processes of single cells can be visualised at the earliest time points, which is not possible in a mouse model. The zebrafish embryonic xenograft of human cancer therefore directly replaces the need for using mouse xenografts and avoids welfare concerns associated with mouse models, including pain and suffering due to unexpected or excessive primary tumour growth. In the UK alone, it is estimated that over 550,000 mice are used each year for cancer research (UK Home Office statistics). On average 50 mice are used per study of cancer metastasis, and over the past 5 years there have been on average 900 publications per year in this area. We therefore estimate that 45,000 mice are used each year for research of cancer metastasis using mouse xenograft models, many of which could be replaced by embryonic zebrafish at unregulated stages of development, using the model described in this paper. To do this several historical concerns need to be addressed.
Experimentally, it is essential that following xenotransplantation human cells can be distinguished from host cells of the zebrafish. Whilst this can be achieved post-mortem by detecting human-specific antigens using immunocytochemistry (Bentley et al., 2015), the use of lipophilic fluorescent cell membrane stains in conjunction with zebrafish transgenic lines allows visualisation of cells both during time-lapse imaging and after tissue fixation. These methods provide equivalent quantification of xenografted cancer cell proliferation (Bentley et al., 2015).
It might be suggested that differences in cell size, microenvironmental niches and molecular signalling pathways between human patients and preclinical models (mice as well as zebrafish) could limit the relevance and translational value of data obtained from animal studies. However, our studies show that human cancer cells are able to invade zebrafish blood vessels and form secondary tumours, which can be inhibited by specific autophagy inhibition (Verykiou et al., 2018); while previous studies have shown that VEGF and CXCR4 signalling are conserved between human cancers and zebrafish (He et al., 2012; Tulotta et al., 2016). Nevertheless, further studies to characterise the response of human cells in the zebrafish model organism are required.
The future direction of research using zebrafish embryos for human xenograft studies will likely focus on strategies and methods to increase assay throughput and improve analysis of large data sets. These objectives will benefit from a number of technical innovations, such as devices to orientate the zebrafish for imaging (Wittbrodt et al., 2014) as well as automated quantification and analysis of tumour cell dissemination (Ghotra et al., 2012; Heilmann et al., 2015). The analysis of in-situ cancer cell proliferation could be improved by using techniques such as EdU incorporation or use of a transgenic cell cycle reporter such as FUCCI within cancer cells (Haass et al., 2014)
Stable cancer cell lines are often dramatically different from patient tumour cells and by definition have been selected for ease of maintenance in the laboratory environment. However, it is likely that heterogeneity and cooperation of cancer cells in patient tumours drives tumour invasion through remodelling of the extracellular matrix (Chapman et al., 2014). Thus, cancer is represented by cells that vary in their proliferative, invasive and metastatic phenotype, which contributes both to tumour growth and also emergence of drug resistance (Anderson et al., 2011). However, it is often not feasible to investigate the effect of tumour cell heterogeneity in mouse xenograft models as large numbers of patient primary tumour cells are required for successful engraftment. In contrast, a major advantage of the embryonic zebrafish xenograft assay is the capacity to accurately detect and monitor a small number of cells (100–200 cells per fish), including low-number cancer subpopulations such as cancer stem cells, drug-resistant cells or primary patient tumour tissue where only small numbers of cells can be recovered e.g. circulating tumour cells. Patient-derived tumour xenograft models are therefore a potential solution to the problem of limited intratumoural heterogeneity of cell line derived xenografts, which may also improve the accuracy of tumour drug-response studies.
It is becoming increasingly clear that no single pre-clinical model can substitute for actual human trials, and therefore as researchers we must continually reassess and adapt our model assays to improve their relevance, which will likely involve employing an approach that combines multicellular in vitro organoid assays (Hill et al., 2015) with both zebrafish and mouse in vivo studies. We suggest that this combinatorial approach will reduce the reliance on mouse xenograft models for the study of human cancer metastasis and drug screening. However, the challenge for translational cancer research will be to integrate the multitude of data from different model organisms to identify evolutionary conserved drug-tumour interactions between species so that we may select the most appropriate therapeutics that have the highest chance of providing an effective treatment for patients with cancer.
Dataset 1. Raw images used to generate figures shown in this study. Shown are images for Figure 1 and Figure 3; images in Figure 2 were obtained from stills of Supplementary Movie 1–Supplementary Movie 3. DOI: https://doi.org/10.5256/f1000research.16659.d221978 (Hill et al., 2018).
This work was supported by grant funding from the National Centre for the Replacement, Reduction and Refinement of Animals in Research (NC3Rs; NC/L002000/1), and from Alpe D'HuZes (AdH)/KWF PROPER (UL2014-7058).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Supplementary File 1. Complete step-by-step protocol for Zebrafish xenograft of human cancer cells.
Supplementary File 2. Completed ARRIVE checklist.
Supplementary Movie 1. Representative time lapse confocal movie showing active invasion of a DiI-labelled A375 melanoma cell through the yolk sac and into a kdrl-GFP labelled blood vessel of a Casper zebrafish embryo.
Images were taken every 15 minutes for 5 hours.
Supplementary Movie 2. 3D rendering of confocal movie showing active invasion of a DiI-labelled A375 melanoma cell through the yolk sac and into a kdrl-GFP labelled blood vessel of a Casper zebrafish embryo.
Transverse field of view through the blood vessel demonstrates that the red melanoma is within the green blood vessel and actively moving against the flow of blood.
Supplementary Movie 3. Representative time lapse confocal movie showing movement of a DiI-labelled A375 melanoma cell through a kdrl-GFP labelled blood vessel of a Casper zebrafish embryo.
Images were taken every 15 minutes for 5 hours.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Is the rationale for developing the new method (or application) clearly explained?
Yes
Is the description of the method technically sound?
Yes
Are sufficient details provided to allow replication of the method development and its use by others?
Partly
If any results are presented, are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions about the method and its performance adequately supported by the findings presented in the article?
Yes
Competing Interests: No competing interests were disclosed.
Is the rationale for developing the new method (or application) clearly explained?
Yes
Is the description of the method technically sound?
Partly
Are sufficient details provided to allow replication of the method development and its use by others?
Partly
If any results are presented, are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions about the method and its performance adequately supported by the findings presented in the article?
Yes
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 2 (revision) 20 Dec 18 |
||
Version 1 22 Oct 18 |
read | read |
Click here to access the data.
Spreadsheet data files may not format correctly if your computer is using different default delimiters (symbols used to separate values into separate cells) - a spreadsheet created in one region is sometimes misinterpreted by computers in other regions. You can change the regional settings on your computer so that the spreadsheet can be interpreted correctly.
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
Please enter your details to receive updates from the NC3Rs
We'll update you about the NC3Rs and the NC3Rs Gateway.
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)